◄ back to all posts

MRNA: Moderna Inc Stock

Written by | Jul 6, 2018

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 50,267.05
Enterprise Value ($M) 41,698.04
Book Value ($M) 2,759.80
Book Value / Share 6.97
Price / Book 15.65
NCAV ($M) 1,686.14
NCAV / Share 4.26
Price / NCAV 25.62

Profitability (mra)
Return on Invested Capital (ROIC) -0.44
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.34

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 2.43

Balance Sheet (mrq) ($M)
Current Assets 3,577.21
Assets 4,650.87
Liabilities 1,891.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 60.21
Operating Income -545.72
Net Income -514.00
Earnings Per Share Basic And Diluted -1.55

Cash Flow Statement (mra) ($M)
Cash From Operations -458.97
Cash from Investing -14.95
Cash from Financing -14.95

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-13 13G/A Flagship Ventures Fund IV General Partner LLC 15.31
2020-02-13 13G/A Bancel Stephane 9.20
2020-02-11 13G/A Viking Global Investors Lp 1.00
2020-02-11 13G Vanguard Group Inc 5.19

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-10-30 10-Q Quarterly Report – 10-Q
2020-08-06 10-Q Quarterly Report – 10-Q
2020-05-07 10-Q Quarterly Report – 10-Q
2020-02-27 10-K Annual Report – 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-11-27 11,411,024 43,293,563 26.36
2020-11-25 5,030,106 25,850,600 19.46
2020-11-24 2,140,894 11,896,764 18.00
2020-11-23 2,812,239 16,359,600 17.19

(click for more detail)

Similar Companies
MORF – Morphic Holding, Inc. MREO – Mereo BioPharma Group plc
MRKR – Marker Therapeutics, Inc. MRNS – Marinus Pharmaceuticals, Inc.
MRSN – Mersana Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

401 K